The partnership will bring together the unique expertise and resources of both institutions to focus on the nanoscale principles and their application to disease identification and treatment development. CNSE is based at Albany NanoTech, one of the largest global centers of nanoscale scientific research with the most extensive nanotechnology facilities in the academic world. Albert Einstein College of Medicine, one of the nation's top medical schools, receives more than $150 million annually in federal support for innovative medical research.
Kermit Hall, Ph.D., President of the University at Albany said, "The 21st Century will be marked by exciting nanotechnology innovations that are enabled by multi-institutional academic enterprises. These innovations will drive the advancement of medicine, biotechnology, and life sciences. This initiative demonstrates the strength of the University's advanced research and our successful partnerships, and we're enormously proud to partner with the Albert Einstein College of Medicine in this important endeavor."
"We are excited to be entering into this strategic partnership with one of the premier medical colleges in the world, particularly as we ramp up our nanobiotechnology research and education initiatives," said Alain Kaloyeros, Ph.D., Vice President and Chief Administrative Officer of CNSE and President of Albany NanoTech. "Nanotechnology holds enormous promise for revolutionizing many areas of our lives, but none more promising than disease identification and treatment. We look forward to collaborating with the distinguished physicians, scientists, and students of the Albert Einstein
'"/>
Contact: Shonna Keogan
skeogan@uamail.albany.edu
917-660-7462
Albany NanoTech College of Nanoscale Science and Engineering
21-Feb-2005